English

CTI MOLECULAR IMAGING INC

EDGAR

Quarterly report (10-Q) · filed 2005-02-09

15 filing records in this dataset, filed from 2002-08-14 to 2005-02-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

111 million USD

2004-12-31 · USD

Exact inputs and evidence

Revenue: 111467000 USD Source

Operating margin

12.72%

2004-12-31 · %

Exact inputs and evidence

Operating Income: 14183000 USD Source
Revenue: 111467000 USD Source

Operating cash flow

-4.3 million USD

2004-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -4296000 USD Source

Free cash flow

-12.9 million USD

2004-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -4296000 USD Source
Capital Expenditure: 8649000 USD Source

Cash and cash equivalents: 24.9 million USD 2004-12-31 Source
Exact value

24853000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

439 million USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Revenue: 106282000 USD · 2004-01-01 – 2004-03-31 Source
Revenue: 91785000 USD · 2004-04-01 – 2004-06-30 Source
Revenue: 401748000 USD · 2003-10-01 – 2004-09-30 Source
Revenue: 272174000 USD · 2003-10-01 – 2004-06-30 Source
Revenue: 111467000 USD · 2004-10-01 – 2004-12-31 Source

Net income

21.9 million USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Net income: 5767000 USD · 2004-01-01 – 2004-03-31 Source
Net income: 2743000 USD · 2004-04-01 – 2004-06-30 Source
Net income: 18620000 USD · 2003-10-01 – 2004-09-30 Source
Net income: 9228000 USD · 2003-10-01 – 2004-06-30 Source
Net income: 3960000 USD · 2004-10-01 – 2004-12-31 Source

Operating cash flow

38.5 million USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Operating cash flow: 27706000 USD · 2003-10-01 – 2004-03-31 Source
Operating cash flow: 5696000 USD · 2003-10-01 – 2003-12-31 Source
Operating cash flow: 27464000 USD · 2003-10-01 – 2004-06-30 Source
Operating cash flow: 27706000 USD · 2003-10-01 – 2004-03-31 Source
Operating cash flow: 48521000 USD · 2003-10-01 – 2004-09-30 Source
Operating cash flow: 27464000 USD · 2003-10-01 – 2004-06-30 Source
Operating cash flow: -4296000 USD · 2004-10-01 – 2004-12-31 Source

Capital expenditure

40 million USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Capital expenditure: 19537000 USD · 2003-10-01 – 2004-03-31 Source
Capital expenditure: 10055000 USD · 2003-10-01 – 2003-12-31 Source
Capital expenditure: 30367000 USD · 2003-10-01 – 2004-06-30 Source
Capital expenditure: 19537000 USD · 2003-10-01 – 2004-03-31 Source
Capital expenditure: 41394000 USD · 2003-10-01 – 2004-09-30 Source
Capital expenditure: 30367000 USD · 2003-10-01 – 2004-06-30 Source
Capital expenditure: 8649000 USD · 2004-10-01 – 2004-12-31 Source

Free cash flow

-1.46 million USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Operating cash flow: 27706000 USD · 2003-10-01 – 2004-03-31 Source
Operating cash flow: 5696000 USD · 2003-10-01 – 2003-12-31 Source
Operating cash flow: 27464000 USD · 2003-10-01 – 2004-06-30 Source
Operating cash flow: 27706000 USD · 2003-10-01 – 2004-03-31 Source
Operating cash flow: 48521000 USD · 2003-10-01 – 2004-09-30 Source
Operating cash flow: 27464000 USD · 2003-10-01 – 2004-06-30 Source
Operating cash flow: -4296000 USD · 2004-10-01 – 2004-12-31 Source
Capital expenditure: 19537000 USD · 2003-10-01 – 2004-03-31 Source
Capital expenditure: 10055000 USD · 2003-10-01 – 2003-12-31 Source
Capital expenditure: 30367000 USD · 2003-10-01 – 2004-06-30 Source
Capital expenditure: 19537000 USD · 2003-10-01 – 2004-03-31 Source
Capital expenditure: 41394000 USD · 2003-10-01 – 2004-09-30 Source
Capital expenditure: 30367000 USD · 2003-10-01 – 2004-06-30 Source
Capital expenditure: 8649000 USD · 2004-10-01 – 2004-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2005-02-09.

Financial data available through: 2004-09-30.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2004-09-30
Operating income: 5 of 11 periods available· newest 2004-09-30
Net income: 5 of 11 periods available· newest 2004-09-30
Operating cash flow: 5 of 11 periods available· newest 2004-09-30
Capital expenditure: 5 of 11 periods available· newest 2004-09-30
Total assets: 4 of 11 periods available· newest 2004-09-30
Total liabilities: 4 of 11 periods available· newest 2004-09-30
Current assets: 4 of 11 periods available· newest 2004-09-30
Current liabilities: 4 of 11 periods available· newest 2004-09-30
Cash and cash equivalents: 5 of 11 periods available· newest 2004-09-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+10.9%

Prior period

USD 362.29 million

2002-10-01 – 2003-09-30
Current period

USD 401.75 million

2003-10-01 – 2004-09-30

Exact inputs and evidence

401748000 − 362289000 = 39459000 USD

362289000 USD · 2002-10-01 – 2003-09-30
Inspect prior input Prior source
401748000 USD · 2003-10-01 – 2004-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CTI MOLECULAR IMAGING INC · 2004-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Year-over-year change in Revenue: 39459000 USD Concept: fundies:Revenue Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 401748000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#19019 Input fundies:Revenue: 362289000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#19019
The citation records this snapshot. The page link may show a newer release later.
Net income
-9.4%

Prior period

USD 20.56 million

2002-10-01 – 2003-09-30
Current period

USD 18.62 million

2003-10-01 – 2004-09-30

Exact inputs and evidence

18620000 − 20563000 = -1943000 USD

20563000 USD · 2002-10-01 – 2003-09-30
Inspect prior input Prior source
18620000 USD · 2003-10-01 – 2004-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CTI MOLECULAR IMAGING INC · 2004-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Year-over-year change in Net income: -1943000 USD Concept: fundies:NetIncome Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 18620000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22414 Input fundies:NetIncome: 20563000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22414
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+194%

Prior period

USD 16.51 million

2002-10-01 – 2003-09-30
Current period

USD 48.52 million

2003-10-01 – 2004-09-30

Exact inputs and evidence

48521000 − 16505000 = 32016000 USD

16505000 USD · 2002-10-01 – 2003-09-30
Inspect prior input Prior source
48521000 USD · 2003-10-01 – 2004-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CTI MOLECULAR IMAGING INC · 2004-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Year-over-year change in Operating cash flow: 32016000 USD Concept: fundies:OperatingCashFlow Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 48521000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22948 Input fundies:OperatingCashFlow: 16505000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22948
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+12.3%

Prior period

USD 36.87 million

2002-10-01 – 2003-09-30
Current period

USD 41.39 million

2003-10-01 – 2004-09-30

Exact inputs and evidence

41394000 − 36866000 = 4528000 USD

36866000 USD · 2002-10-01 – 2003-09-30
Inspect prior input Prior source
41394000 USD · 2003-10-01 – 2004-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CTI MOLECULAR IMAGING INC · 2004-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Year-over-year change in Capital expenditure: 4528000 USD Concept: fundies:CapitalExpenditure Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 41394000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#23009 Input fundies:CapitalExpenditure: 36866000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#23009
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2004 2003-10-01 – 2004-09-30

Revenue USD 401.75 million 100% of revenue
Operating costs Derived USD 343.74 million 86% of revenue
Operating income USD 58 million 14% of revenue
Tax, interest and other Derived USD 39.38 million 9.8% of revenue
Net income USD 18.62 million 4.6% of revenue

Cash

Operating cash flow USD 48.52 million 12% of revenue
Capital expenditure USD 41.39 million 10% of revenue
Free cash flow Derived USD 7.13 million 1.8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 11%85%
2001 12%84%
2002 Net loss: net income was −1.3% of revenue.
2003 10%84%
2004 9.8%86%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 1999-10-01 – 2000-09-30	124026000	105471000 Derived	18555000	14177000 Derived	4378000	-16922000 Derived	Source 1999-10-01 – 2000-09-30: 124026000 USD Inspect Revenue Open source 1999-10-01 – 2000-09-30: 18555000 USD Inspect Operating Income Open source 1999-10-01 – 2000-09-30: 4378000 USD Inspect Net Income Open source 1999-10-01 – 2000-09-30: -10647000 USD Inspect Operating Cash Flow Open source 1999-10-01 – 2000-09-30: 6275000 USD Inspect Capital Expenditure Open source
2001 2000-10-01 – 2001-09-30	188877000	159205000 Derived	29672000	23556000 Derived	6116000	-21246000 Derived	Source 2000-10-01 – 2001-09-30: 188877000 USD Inspect Revenue Open source 2000-10-01 – 2001-09-30: 29672000 USD Inspect Operating Income Open source 2000-10-01 – 2001-09-30: 6116000 USD Inspect Net Income Open source 2000-10-01 – 2001-09-30: -10884000 USD Inspect Operating Cash Flow Open source 2000-10-01 – 2001-09-30: 10362000 USD Inspect Capital Expenditure Open source
2002 2001-10-01 – 2002-09-30	258395000	221631000 Derived	36764000	40183000 Derived	-3419000	1614000 Derived	Source 2001-10-01 – 2002-09-30: 258395000 USD Inspect Revenue Open source 2001-10-01 – 2002-09-30: 36764000 USD Inspect Operating Income Open source 2001-10-01 – 2002-09-30: -3419000 USD Inspect Net Income Open source 2001-10-01 – 2002-09-30: 31047000 USD Inspect Operating Cash Flow Open source 2001-10-01 – 2002-09-30: 29433000 USD Inspect Capital Expenditure Open source
2003 2002-10-01 – 2003-09-30	362289000	304568000 Derived	57721000	37158000 Derived	20563000	-20361000 Derived	Source 2002-10-01 – 2003-09-30: 362289000 USD Inspect Revenue Open source 2002-10-01 – 2003-09-30: 57721000 USD Inspect Operating Income Open source 2002-10-01 – 2003-09-30: 20563000 USD Inspect Net Income Open source 2002-10-01 – 2003-09-30: 16505000 USD Inspect Operating Cash Flow Open source 2002-10-01 – 2003-09-30: 36866000 USD Inspect Capital Expenditure Open source
2004 2003-10-01 – 2004-09-30	401748000	343744000 Derived	58004000	39384000 Derived	18620000	7127000 Derived	Source 2003-10-01 – 2004-09-30: 401748000 USD Inspect Revenue Open source 2003-10-01 – 2004-09-30: 58004000 USD Inspect Operating Income Open source 2003-10-01 – 2004-09-30: 18620000 USD Inspect Net Income Open source 2003-10-01 – 2004-09-30: 48521000 USD Inspect Operating Cash Flow Open source 2003-10-01 – 2004-09-30: 41394000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 401.7M 2004

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-09-30	Revenue	124026000	Revenue: 124026000 Open source
20012001-09-30	Revenue	188877000	Revenue: 188877000 Open source
20022002-09-30	Revenue	258395000	Revenue: 258395000 Open source
20032003-09-30	Revenue	362289000	Revenue: 362289000 Open source
20042004-09-30	Revenue	401748000	Revenue: 401748000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

10.9% 2004

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-09-30	Year over year	No prior comparable period	Revenue: 124026000 Open source
20012001-09-30	Year over year	52.3%	Revenue: 188877000 Open source Revenue: 124026000 Open source
20022002-09-30	Year over year	36.8%	Revenue: 258395000 Open source Revenue: 188877000 Open source
20032003-09-30	Year over year	40.2%	Revenue: 362289000 Open source Revenue: 258395000 Open source
20042004-09-30	Year over year	10.9%	Revenue: 401748000 Open source Revenue: 362289000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 14.4% 2004

Net margin 4.6% 2004

Free cash flow margin 1.8% 2004

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-09-30	Operating margin	15%	Operating Income: 18555000 Open source Revenue: 124026000 Open source
20012001-09-30	Operating margin	15.7%	Operating Income: 29672000 Open source Revenue: 188877000 Open source
20022002-09-30	Operating margin	14.2%	Operating Income: 36764000 Open source Revenue: 258395000 Open source
20032003-09-30	Operating margin	15.9%	Operating Income: 57721000 Open source Revenue: 362289000 Open source
20042004-09-30	Operating margin	14.4%	Operating Income: 58004000 Open source Revenue: 401748000 Open source
20002000-09-30	Net margin	3.5%	Net Income: 4378000 Open source Revenue: 124026000 Open source
20012001-09-30	Net margin	3.2%	Net Income: 6116000 Open source Revenue: 188877000 Open source
20022002-09-30	Net margin	-1.3%	Net Income: -3419000 Open source Revenue: 258395000 Open source
20032003-09-30	Net margin	5.7%	Net Income: 20563000 Open source Revenue: 362289000 Open source
20042004-09-30	Net margin	4.6%	Net Income: 18620000 Open source Revenue: 401748000 Open source
20002000-09-30	Free cash flow margin	-13.6%	Revenue: 124026000 Open source Operating Cash Flow: -10647000 Open source Capital Expenditure: 6275000 Open source
20012001-09-30	Free cash flow margin	-11.2%	Revenue: 188877000 Open source Operating Cash Flow: -10884000 Open source Capital Expenditure: 10362000 Open source
20022002-09-30	Free cash flow margin	0.6%	Revenue: 258395000 Open source Operating Cash Flow: 31047000 Open source Capital Expenditure: 29433000 Open source
20032003-09-30	Free cash flow margin	-5.6%	Revenue: 362289000 Open source Operating Cash Flow: 16505000 Open source Capital Expenditure: 36866000 Open source
20042004-09-30	Free cash flow margin	1.8%	Revenue: 401748000 Open source Operating Cash Flow: 48521000 Open source Capital Expenditure: 41394000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 48.5M 2004

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-09-30	Operating cash flow	-10647000	Operating Cash Flow: -10647000 Open source
20012001-09-30	Operating cash flow	-10884000	Operating Cash Flow: -10884000 Open source
20022002-09-30	Operating cash flow	31047000	Operating Cash Flow: 31047000 Open source
20032003-09-30	Operating cash flow	16505000	Operating Cash Flow: 16505000 Open source
20042004-09-30	Operating cash flow	48521000	Operating Cash Flow: 48521000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 7.1M 2004

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-09-30	Free cash flow	-16922000	Operating Cash Flow: -10647000 Open source Capital Expenditure: 6275000 Open source
20012001-09-30	Free cash flow	-21246000	Operating Cash Flow: -10884000 Open source Capital Expenditure: 10362000 Open source
20022002-09-30	Free cash flow	1614000	Operating Cash Flow: 31047000 Open source Capital Expenditure: 29433000 Open source
20032003-09-30	Free cash flow	-20361000	Operating Cash Flow: 16505000 Open source Capital Expenditure: 36866000 Open source
20042004-09-30	Free cash flow	7127000	Operating Cash Flow: 48521000 Open source Capital Expenditure: 41394000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

20.6% 2004

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2000-09-30	Liabilities / assets	Not reported	No source recorded
20012001-09-30	Liabilities / assets	72%	Total Liabilities: 149532000 Open source Total Assets: 207781000 Open source
20022002-09-30	Liabilities / assets	29%	Total Liabilities: 102116000 Open source Total Assets: 351709000 Open source
20032003-09-30	Liabilities / assets	27.9%	Total Liabilities: 118468000 Open source Total Assets: 425048000 Open source
20042004-09-30	Liabilities / assets	20.6%	Total Liabilities: 95949000 Open source Total Assets: 465214000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.4× 2004

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2000-09-30	Current assets / current liabilities	Not reported	No source recorded
20012001-09-30	Current assets / current liabilities	2.16×	Current Assets: 138853000 Open source Current Liabilities: 64191000 Open source
20022002-09-30	Current assets / current liabilities	3.38×	Current Assets: 250226000 Open source Current Liabilities: 73966000 Open source
20032003-09-30	Current assets / current liabilities	2.95×	Current Assets: 260942000 Open source Current Liabilities: 88449000 Open source
20042004-09-30	Current assets / current liabilities	3.4×	Current Assets: 250596000 Open source Current Liabilities: 73633000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 1999-10-01 – 2000-09-30	USD 4.38 million Exact value Exact value: 4378000 USD 1999-10-01 – 2000-09-30: 4378000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTI MOLECULAR IMAGING INC · 2000-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Net Income: 4378000 USD Concept: fundies:NetIncome Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ANetIncome&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:NetIncome: 4378000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-02-012935.txt#22326 The citation records this snapshot. The page link may show a newer release later.	−USD 10.65 million Exact value Exact value: -10647000 USD 1999-10-01 – 2000-09-30: -10647000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTI MOLECULAR IMAGING INC · 2000-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Operating Cash Flow: -10647000 USD Concept: fundies:OperatingCashFlow Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3AOperatingCashFlow&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10647000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-02-012935.txt#22816 The citation records this snapshot. The page link may show a newer release later.	USD 6.28 million Exact value Exact value: 6275000 USD 1999-10-01 – 2000-09-30: 6275000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CTI MOLECULAR IMAGING INC · 2000-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Capital Expenditure: 6275000 USD Concept: fundies:CapitalExpenditure Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ACapitalExpenditure&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6275000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-02-012935.txt#22920 The citation records this snapshot. The page link may show a newer release later.	−USD 16.92 million Calculation and evidence -10647000 − 6275000 USD Exact free cash flow: -16922000 USD 1999-10-01 – 2000-09-30: -10647000 USD · Inspect Operating Cash Flow · Source 1999-10-01 – 2000-09-30: 6275000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CTI MOLECULAR IMAGING INC · 2000-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Free cash flow: -16922000 USD Concept: free-cash-flow Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10647000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-02-012935.txt#22816 Input fundies:CapitalExpenditure: 6275000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-02-012935.txt#22920 The citation records this snapshot. The page link may show a newer release later.
2001 2000-10-01 – 2001-09-30	USD 6.12 million Exact value Exact value: 6116000 USD 2000-10-01 – 2001-09-30: 6116000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTI MOLECULAR IMAGING INC · 2001-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Net Income: 6116000 USD Concept: fundies:NetIncome Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ANetIncome&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:NetIncome: 6116000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-03-013952.txt#21846 The citation records this snapshot. The page link may show a newer release later.	−USD 10.88 million Exact value Exact value: -10884000 USD 2000-10-01 – 2001-09-30: -10884000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTI MOLECULAR IMAGING INC · 2001-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Operating Cash Flow: -10884000 USD Concept: fundies:OperatingCashFlow Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3AOperatingCashFlow&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10884000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-03-013952.txt#22402 The citation records this snapshot. The page link may show a newer release later.	USD 10.36 million Exact value Exact value: 10362000 USD 2000-10-01 – 2001-09-30: 10362000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CTI MOLECULAR IMAGING INC · 2001-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Capital Expenditure: 10362000 USD Concept: fundies:CapitalExpenditure Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ACapitalExpenditure&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10362000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-03-013952.txt#22464 The citation records this snapshot. The page link may show a newer release later.	−USD 21.25 million Calculation and evidence -10884000 − 10362000 USD Exact free cash flow: -21246000 USD 2000-10-01 – 2001-09-30: -10884000 USD · Inspect Operating Cash Flow · Source 2000-10-01 – 2001-09-30: 10362000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CTI MOLECULAR IMAGING INC · 2001-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Free cash flow: -21246000 USD Concept: free-cash-flow Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10884000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-03-013952.txt#22402 Input fundies:CapitalExpenditure: 10362000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-03-013952.txt#22464 The citation records this snapshot. The page link may show a newer release later.
2002 2001-10-01 – 2002-09-30	−USD 3.42 million Exact value Exact value: -3419000 USD 2001-10-01 – 2002-09-30: -3419000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTI MOLECULAR IMAGING INC · 2002-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Net Income: -3419000 USD Concept: fundies:NetIncome Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ANetIncome&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:NetIncome: -3419000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22414 The citation records this snapshot. The page link may show a newer release later.	USD 31.05 million Exact value Exact value: 31047000 USD 2001-10-01 – 2002-09-30: 31047000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTI MOLECULAR IMAGING INC · 2002-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Operating Cash Flow: 31047000 USD Concept: fundies:OperatingCashFlow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3AOperatingCashFlow&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 31047000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22948 The citation records this snapshot. The page link may show a newer release later.	USD 29.43 million Exact value Exact value: 29433000 USD 2001-10-01 – 2002-09-30: 29433000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CTI MOLECULAR IMAGING INC · 2002-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Capital Expenditure: 29433000 USD Concept: fundies:CapitalExpenditure Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ACapitalExpenditure&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29433000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#23009 The citation records this snapshot. The page link may show a newer release later.	USD 1.61 million Calculation and evidence 31047000 − 29433000 USD Exact free cash flow: 1614000 USD 2001-10-01 – 2002-09-30: 31047000 USD · Inspect Operating Cash Flow · Source 2001-10-01 – 2002-09-30: 29433000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CTI MOLECULAR IMAGING INC · 2002-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Free cash flow: 1614000 USD Concept: free-cash-flow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 31047000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22948 Input fundies:CapitalExpenditure: 29433000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#23009 The citation records this snapshot. The page link may show a newer release later.
2003 2002-10-01 – 2003-09-30	USD 20.56 million Exact value Exact value: 20563000 USD 2002-10-01 – 2003-09-30: 20563000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTI MOLECULAR IMAGING INC · 2003-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Net Income: 20563000 USD Concept: fundies:NetIncome Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ANetIncome&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:NetIncome: 20563000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22414 The citation records this snapshot. The page link may show a newer release later.	USD 16.51 million Exact value Exact value: 16505000 USD 2002-10-01 – 2003-09-30: 16505000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTI MOLECULAR IMAGING INC · 2003-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Operating Cash Flow: 16505000 USD Concept: fundies:OperatingCashFlow Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3AOperatingCashFlow&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 16505000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22948 The citation records this snapshot. The page link may show a newer release later.	USD 36.87 million Exact value Exact value: 36866000 USD 2002-10-01 – 2003-09-30: 36866000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CTI MOLECULAR IMAGING INC · 2003-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Capital Expenditure: 36866000 USD Concept: fundies:CapitalExpenditure Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ACapitalExpenditure&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36866000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#23009 The citation records this snapshot. The page link may show a newer release later.	−USD 20.36 million Calculation and evidence 16505000 − 36866000 USD Exact free cash flow: -20361000 USD 2002-10-01 – 2003-09-30: 16505000 USD · Inspect Operating Cash Flow · Source 2002-10-01 – 2003-09-30: 36866000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CTI MOLECULAR IMAGING INC · 2003-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Free cash flow: -20361000 USD Concept: free-cash-flow Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 16505000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22948 Input fundies:CapitalExpenditure: 36866000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#23009 The citation records this snapshot. The page link may show a newer release later.
2004 2003-10-01 – 2004-09-30	USD 18.62 million Exact value Exact value: 18620000 USD 2003-10-01 – 2004-09-30: 18620000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CTI MOLECULAR IMAGING INC · 2004-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Net Income: 18620000 USD Concept: fundies:NetIncome Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ANetIncome&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:NetIncome: 18620000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22414 The citation records this snapshot. The page link may show a newer release later.	USD 48.52 million Exact value Exact value: 48521000 USD 2003-10-01 – 2004-09-30: 48521000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CTI MOLECULAR IMAGING INC · 2004-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Operating Cash Flow: 48521000 USD Concept: fundies:OperatingCashFlow Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3AOperatingCashFlow&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 48521000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22948 The citation records this snapshot. The page link may show a newer release later.	USD 41.39 million Exact value Exact value: 41394000 USD 2003-10-01 – 2004-09-30: 41394000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CTI MOLECULAR IMAGING INC · 2004-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Capital Expenditure: 41394000 USD Concept: fundies:CapitalExpenditure Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552/explain?concept=fundies%3ACapitalExpenditure&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 41394000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#23009 The citation records this snapshot. The page link may show a newer release later.	USD 7.13 million Calculation and evidence 48521000 − 41394000 USD Exact free cash flow: 7127000 USD 2003-10-01 – 2004-09-30: 48521000 USD · Inspect Operating Cash Flow · Source 2003-10-01 – 2004-09-30: 41394000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CTI MOLECULAR IMAGING INC · 2004-09-30 CTI MOLECULAR IMAGING INC (edgar:1129552) Free cash flow: 7127000 USD Concept: free-cash-flow Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-03T18:52:50Z Snapshot: 5e4aabae352d78b8bfcdcd75128e37b38abff6c874cfaa66c88fca55d3a24142 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 48521000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#22948 Input fundies:CapitalExpenditure: 41394000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129552/0000950144-04-012040.txt#23009 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

15 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0001129552, 1129552, edgar:1129552

Also known as CTI INC /TN

CTI MOLECULAR IMAGING INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2004 2003-10-01 – 2004-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation